Upload Avatar (500 x 500)
Gao Feng
Life Science
University of Chinese Academy of Sciences
Tianjin
Language: Chinese, English
Biotechnology
Immunology
Virology
Antibody
Molecular Biology
Microbiology
Vaccine
Infectious Diseases
Protein
Genetic Engineering
Areas of Focus
- Biotechnology
- Immunology
- Virology
- Antibody Engineering
- Molecular Biology
- Microbiology
- Vaccine Development
- Infectious Diseases
- Protein Engineering
- Genetic Engineering
Work Experience
- 2019-01~Present - Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences - Associate Researcher
- 2014-07~2019-02 - Institute of Genetics and Developmental Biology, Chinese Academy of Sciences - Assistant Researcher
- 2010-09~2014-06 - Sichuan University - PhD
- 2007-06~2010-08 - Institute of Biophysics, Chinese Academy of Sciences - Assistant Researcher
- 2004-09~2008-06 - Chinese Academy of Agricultural Sciences - Master's
- 2004-09~2007-05 - Institute of Microbiology, Chinese Academy of Sciences - Assistant Researcher
- 2003-10~2004-08 - Avidex, UK - Senior Engineer
- 1998-07~2003-09 - School of Life Sciences, Tsinghua University - Engineer
- 1994-09~1998-06 - China Agricultural University - Bachelor's
Academic Background & Achievements
- 2010-09--2014-06 PhD: Sichuan University
- 2004-09--2008-06 Master's: Chinese Academy of Agricultural Sciences
- 1994-09--1998-06 Bachelor's: China Agricultural University
Publications
- Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2, Not mentioned, 2023
- Structural and inhibitor sensitivity analysis of influenza B-like viral neuraminidases derived from Asiatic toad and spiny eel, Not mentioned, 2022
- An engineered bispecific human monoclonal antibody against SARS-CoV-2, Not mentioned, 2022
- Human infection of avian influenza A H3N8 virus and the viral origins: a descriptive study, Not mentioned, 2022
- O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an 'O-Follow-N' rule, Not mentioned, 2021
- A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2, Not mentioned, 2020
- Molecular Basis of Arthritogenic Alphavirus Receptor MXRA8 Binding to Chikungunya Virus Envelope Protein, Not mentioned, 2019
